Logo
x

Search

Subscribe Now

Adolescents

Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Expanded Use to Treat Paroxysmal Nocturnal Haemoglobinuria

Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Expanded Use to Treat Paroxysmal Nocturnal Haemoglobinuria

  • September 3, 2021
Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

  • July 26, 2021
Pfizer and BioNTech Receive EC's Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents

Pfizer and BioNTech Receive EC's Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents

  • May 31, 2021
Moderna's mRNA-1273 Meets its Primary Endpoint in P-II/III TeenCOVE Study to Prevent COVID 19 in Adolescents

Moderna's mRNA-1273 Meets its Primary Endpoint in P-II/III TeenCOVE Study to Prevent COVID 19 in Adolescents

  • May 26, 2021
GSK's Nucala Receives Health Canada's Approval for Severe Eosinophilic Asthma in Children and Adolescents

GSK's Nucala Receives Health Canada's Approval for Severe Eosinophilic Asthma in Children and Adolescents

  • March 17, 2020
Alnylam's Givlaari (givosiran) Receives EC's Approval for Acute Hepatic Porphyria in Adults and Adolescents

Alnylam's Givlaari (givosiran) Receives EC's Approval for Acute Hepatic Porphyria in Adults and Adolescents

  • March 4, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.